Related Experiment Video
Updated: Jun 2, 2026
08:50
How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
Predicting potential placebo effect in drug treated subjects
Eva Petkova1, Thaddeus Tarpey, Usha Govindarajulu
1New York University, USA.
The International Journal of Biostatistics
|May 11, 2011
Summary
This study introduces a new statistical model to separate drug effects from placebo responses in mental illness treatment. This method helps quantify the true chemical impact of medications like fluoxetine for depression.
Area of Science:
- Psychiatry and Pharmaceutical Sciences
- Clinical Trial Methodology
- Statistical Modeling in Healthcare
Background:
- Non-specific treatment responses, or placebo effects, significantly influence outcomes in mental illness treatment.
- Distinguishing between drug-specific effects and placebo responses is crucial for accurate treatment evaluation.
- Existing methods often struggle to isolate the precise chemical impact of therapeutic drugs.
Purpose of the Study:
- To present a novel statistical model for separately predicting specific drug effects and non-specific placebo effects.
- To provide a quantitative method for disentangling the chemical action of a drug from contextual treatment factors.
- To enhance the precision of clinical trial data interpretation in psychopharmacology.
Main Methods:
- Development of a unique statistical model designed for effect separation.
- Application of the model to clinical trial data comparing fluoxetine with a placebo.
- Comparative analysis of drug-treated subjects to isolate specific and non-specific response components.
Main Results:
- The statistical model successfully allowed for the separate prediction of specific drug effects and non-specific effects.
- Demonstrated the ability to quantify the distinct contributions of fluoxetine's chemical action versus placebo response in depression.
- Provided empirical evidence for the model's utility in a real-world clinical trial setting.
Conclusions:
- The proposed statistical model offers a valuable tool for accurately assessing drug efficacy in mental health.
- This methodology can improve the interpretation of clinical trial results by isolating true pharmacological effects.
- Further application of this model can refine our understanding of treatment responses in psychopharmacology.
Keywords:
BLUPallometric extensionlinear mixed effects modelslongitudinal outcomenon-specific treatment effectprincipal componentsspecific drug effectMore Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
09:38Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Related Concept Videos
01:54The Placebo Effect
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...